IPAS770
Concessão de registro em designação
RPI 2807
22/10/2024
Voltar para busca
Dado oficial do INPI
BR500000501745579
Sabia que essa marca já está registrada no Brasil?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Registro de marca em vigor (Madri)Tipo: FigurativaEscritório: Brasil
Andamento no INPI
- Depósito04/04/23
- Publicação05/03/24
- Exame
- Deferimento20/08/24
- Concessão22/10/24
- Vigente04/04/33
Registro concedido em 22/10/2024 e em vigor até 04/04/2033, quando precisa ser renovado.
Proteção válida até:04/04/2033
Última movimentação publicada pelo INPI: 22/10/2024. Atualizamos a cada nova RPI, publicada semanalmente.
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação INPI
Registro de marca em vigor (Madri)
Tipo de processo
Pedido e registro
Eventos registrados
3
Atualização mais recente
22/10/2024
Tipo de marca
Figurativa
Classes Nice
5, 42
Data de depósito
04/04/2023
Data de registro
22/10/2024
Data de expiração
04/04/2033
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Natureza
Madri
Produto/Serviço
Escritório responsável
Brasil
Tipo de titular
NÃO RESIDENTE
Localização do titular
US
Titulares e representantes
Titulares
Eikon Therapeutics, Inc.
Representantes
Sem dados de representantes.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
26.1.1226.7.426.1.3
Produtos e serviços
Classe 5
Pharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders, and vaccinespharmaceutical products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disordersbiopharmaceuticals for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorderstherapeutic products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disordersdiagnostic products, preparations and agents for medicinal purposes
Classe 42
Pharmaceutical drug discovery and development servicesscientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and developmentdrug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industriesproviding temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and developmentproviding temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development servicesdrug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testingresearch and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicinesbiomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disordersmedical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disordersresearch, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticalsscientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disordersscientific laboratory services, namely, live cell imaging analysiscustom design and development of cells, cell lines and assaysbiomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and developmentproviding information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals via a websiteprovision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trialsproviding technology that allows users to conduct drug discovery and development via a websiteproviding technology that allows users to track and measure movement of proteins in living cells via a website
Publicações
Histórico de despachos e eventos da marca no INPI.
3 publicações encontradas
IPAS768
Deferimento de designação
RPI 2798
20/08/2024
IPAS756
Publicação de pedido de registro para oposição (exame formal de designação concluído)
RPI 2774
05/03/2024
Marcas relacionadas
Outras marcas de Eikon Therapeutics, Inc.
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BR500000501745579 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o INPI por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.